{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T18:30:43Z","timestamp":1786559443775,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,12]]},"DOI":"10.7759\/cureus.114432","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T17:59:58Z","timestamp":1786557598000},"source":"Crossref","is-referenced-by-count":0,"title":["Antinuclear Antibody (ANA)\u2011Negative, Anti-melanoma Differentiation-Associated Gene 5 (MDA5)\u2011Positive Dermatomyositis Presenting as Rapidly Progressive Interstitial Lung Disease: A Case Report"],"prefix":"10.7759","author":[{"given":"Joy","family":"Nish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabel","family":"Crippen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2009.328","article-title":"Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota","volume":"146","author":"Bendewald MJ","year":"2010","unstructured":"Bendewald MJ, Wetter DA, Li X, Davis MD. Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota. Arch Dermatol. 2010, 146:26-30. 10.1001\/archdermatol.2009.328","journal-title":"Arch Dermatol"},{"key":"ref2","article-title":"Dermatomyositis","author":"Qudsiya Z","year":"2026","unstructured":"Qudsiya Z, Waseem M. Dermatomyositis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2026."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.773352","article-title":"Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies","volume":"12","author":"Nombel A","year":"2021","unstructured":"Nombel A, Fabien N, Coutant F. Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies. Front Immunol. 2021, 12:773352. 10.3389\/fimmu.2021.773352","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.54660","article-title":"Anti-MDA5 antibody-positive clinically amyopathic dermatomyositis associated with multiple heterologous carcinomas: a case report","volume":"16","author":"Nakano Y","year":"2024","unstructured":"Nakano Y, Nishida K, Okamoto N, Gohma I, Yasuhara Y. Anti-MDA5 antibody-positive clinically amyopathic dermatomyositis associated with multiple heterologous carcinomas: a case report. Cureus. 2024, 16:e54660. 10.7759\/cureus.54660","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S381472","article-title":"Dermatomyositis: practical guidance and unmet needs","volume":"13","author":"Cassard L","year":"2024","unstructured":"Cassard L, Seraly N, Riegert M, Patel A, Fernandez AP. Dermatomyositis: practical guidance and unmet needs. Immunotargets Ther. 2024, 13:151-72. 10.2147\/ITT.S381472","journal-title":"Immunotargets Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.09.016","article-title":"The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study","volume":"65","author":"Fiorentino D","year":"2011","unstructured":"Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol. 2011, 65:25-34. 10.1016\/j.jaad.2010.09.016","journal-title":"J Am Acad Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2025.06.283","article-title":"Classic and clinically amyopathic dermatomyositis: autoantibody positivity","volume":"145","author":"Yang X","year":"2025","unstructured":"Yang X, Chambers S, On A, et al.. Classic and clinically amyopathic dermatomyositis: autoantibody positivity. J Invest Dermatol. 2025, 145:48. 10.1016\/j.jid.2025.06.283","journal-title":"J Invest Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-009-0155-3","article-title":"Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases","volume":"19","author":"Satoh M","year":"2009","unstructured":"Satoh M, V\u00e1zquez-Del Mercado M, Chan EK. Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases. Mod Rheumatol. 2009, 19:219-28. 10.3109\/s10165-009-0155-3","journal-title":"Mod Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12792","article-title":"TEST performance of a myositis panel in a clinical immunology laboratory in New South Wales, Australia","volume":"19","author":"Tan TC","year":"2016","unstructured":"Tan TC, Wienholt L, Adelstein S. TEST performance of a myositis panel in a clinical immunology laboratory in New South Wales, Australia. Int J Rheum Dis. 2016, 19:996-1001. 10.1111\/1756-185X.12792","journal-title":"Int J Rheum Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.1516-18","article-title":"Clinical features of anti-MDA5 antibody-positive rapidly progressive interstitial lung disease without signs of dermatomyositis","volume":"58","author":"Sakamoto N","year":"2019","unstructured":"Sakamoto N, Ishimoto H, Nakashima S, et al.. Clinical features of anti-MDA5 antibody-positive rapidly progressive interstitial lung disease without signs of dermatomyositis. Intern Med. 2019, 58:837-41. 10.2169\/internalmedicine.1516-18","journal-title":"Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15716","article-title":"Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis","volume":"8","author":"Li L","year":"2017","unstructured":"Li L, Wang Q, Yang F, et al.. Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis. Oncotarget. 2017, 8:26552-64. 10.18632\/oncotarget.15716","journal-title":"Oncotarget"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154285","article-title":"Clinical utility of an enzyme-linked immunosorbent assay for detecting anti-melanoma differentiation-associated gene 5 autoantibodies","volume":"11","author":"Sato S","year":"2016","unstructured":"Sato S, Murakami A, Kuwajima A, et al.. Clinical utility of an enzyme-linked immunosorbent assay for detecting anti-melanoma differentiation-associated gene 5 autoantibodies. PLoS One. 2016, 11:e0154285. 10.1371\/journal.pone.0154285","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac229","article-title":"Evaluation and validation of the prognostic value of anti-MDA5 IgG subclasses in dermatomyositis-associated interstitial lung disease","volume":"62","author":"Xu YT","year":"2022","unstructured":"Xu YT, Zhang YM, Yang HX, et al.. Evaluation and validation of the prognostic value of anti-MDA5 IgG subclasses in dermatomyositis-associated interstitial lung disease. Rheumatology (Oxford). 2022, 62:397-406. 10.1093\/rheumatology\/keac229","journal-title":"Rheumatology (Oxford)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-03921-y","article-title":"Anti-MDA5 antibody IgG1 subtype is associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis","volume":"20","author":"Wu Y","year":"2025","unstructured":"Wu Y, Wang Y, Qiu Y, et al.. Anti-MDA5 antibody IgG1 subtype is associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis. Orphanet J Rare Dis. 2025, 20:434. 10.1186\/s13023-025-03921-y","journal-title":"Orphanet J Rare Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/rheumato4010004","article-title":"A review of MDA-5 dermatomyositis and associated interstitial lung disease","volume":"4","author":"Bhandari S","year":"2024","unstructured":"Bhandari S, Zickuhr L, Baral MR, et al.. A review of MDA-5 dermatomyositis and associated interstitial lung disease. Rheumato. 2024, 4:33-48. 10.3390\/rheumato4010004","journal-title":"Rheumato"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-024-01300-8","article-title":"Treatment strategies in MDA5-positive clinically amyopathic dermatomyositis: a single-center retrospective analysis","volume":"24","author":"Hirsch S","year":"2024","unstructured":"Hirsch S, P\u00f6hler GH, Seeliger B, Prasse A, Witte T, Thiele T. Treatment strategies in MDA5-positive clinically amyopathic dermatomyositis: a single-center retrospective analysis. Clin Exp Med. 2024, 24:37. 10.1007\/s10238-024-01300-8","journal-title":"Clin Exp Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.625495","article-title":"Case report: rapidly progressive interstitial lung disease in a pregnant patient with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis","volume":"12","author":"Chen C","year":"2021","unstructured":"Chen C, Chen Y, Huang Q, Hu Q, Hong X. Case report: rapidly progressive interstitial lung disease in a pregnant patient with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis. Front Immunol. 2021, 12:625495. 10.3389\/fimmu.2021.625495","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2021.101464","article-title":"Early intervention of plasma exchange combined with intensive immunosuppressive treatment for anti-MDA-5 antibody-positive rapidly progressive interstitial pneumonia: two case reports","volume":"33","author":"Ishiwari M","year":"2021","unstructured":"Ishiwari M, Togashi Y, Takoi H, et al.. Early intervention of plasma exchange combined with intensive immunosuppressive treatment for anti-MDA-5 antibody-positive rapidly progressive interstitial pneumonia: two case reports. Respir Med Case Rep. 2021, 33:101464. 10.1016\/j.rmcr.2021.101464","journal-title":"Respir Med Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/515930-antinuclear-antibody-ananegative-anti-melanoma-differentiation-associated-gene-5-mda5positive-dermatomyositis-presenting-as-rapidly-progressive-interstitial-lung-disease-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T17:59:59Z","timestamp":1786557599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/515930-antinuclear-antibody-ananegative-anti-melanoma-differentiation-associated-gene-5-mda5positive-dermatomyositis-presenting-as-rapidly-progressive-interstitial-lung-disease-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.114432","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,12]]}}}